Advertisement
Screener

Shattuck Labs, Inc. (STTK) Net Margin

Shattuck Labs, Inc. Net Margin

Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • Shattuck Labs, Inc. net margin for the quarter ending 2025-09-30 was -1005.60%, a change of -449.21% year-over-year.
  • Shattuck Labs, Inc. net margin for the quarter ending 2024-09-30 was -556.39%, a change of 3458.33% year-over-year.
  • Shattuck Labs, Inc. net margin for the quarter ending 2024-06-30 was -1339.47%, a change of 9333.53% year-over-year.
  • Shattuck Labs, Inc. net margin for the quarter ending 2024-03-31 was -1659.55%, a change of 34698.34% year-over-year.
  • Shattuck Labs, Inc. net margin for fiscal 2025 was -4880.90%, a change of -3562.77% from fiscal 2024.
  • Shattuck Labs, Inc. net margin for fiscal 2024 was -1318.13%, a change of 3950.31% from fiscal 2023.
  • Shattuck Labs, Inc. net margin for fiscal 2023 was -5268.44%, a change of 10367.30% from fiscal 2022.
  • Shattuck Labs, Inc. net margin for fiscal 2022 was -15635.74%, a change of -15485.91% from fiscal 2021.
Available history
2019-09-30 to 2025-12-31
Data captured

Historical Net Margin

DateNet MarginNet incomeRevenue
2025-09-30-1005.60%-$10.06M$1M
2024-09-30-556.39%-$16.68M$3M
2024-06-30-1339.47%-$21.55M$1.61M
2024-03-31-1659.55%-$18.5M$1.12M
2023-12-31-2477.17%-$17.69M$714,000.00
2023-09-30-4014.72%-$27.54M$686,000.00
2023-06-30-10673.00%-$21.35M$200,000.00
2023-03-31-36357.89%-$20.72M$57,000.00
2022-12-31-6515.64%-$25.41M$390,000.00
2022-09-30-11620.28%-$24.64M$212,000.00
2022-06-30-54742.00%-$27.37M$50,000.00
2021-12-3126.09%$7.85M$30.08M
2021-09-30-916.32%-$17.41M$1.9M
2021-06-30557.74%-$23.6M-$4.23M
2021-03-31-520.40%-$11.81M$2.27M
2020-12-31-895.08%-$12.01M$1.34M
2020-09-30-485.79%-$11.83M$2.44M
2020-06-30-195.16%-$6.21M$3.18M
2020-03-31-220.23%-$6.55M$2.98M
2019-12-31-261.22%-$7.37M$2.82M
2019-09-30-408.02%-$7.28M$1.78M

Annual Net Margin

DateNet MarginNet incomeRevenue
2025-12-31-4880.90%-$48.81M$1M
2024-12-31-1318.13%-$75.41M$5.72M
2023-12-31-5268.44%-$87.3M$1.66M
2022-12-31-15635.74%-$101.95M$652,000.00
2021-12-31-149.83%-$44.97M$30.02M
2020-12-31-368.46%-$36.6M$9.93M
2019-12-31-242.56%-$23.98M$9.89M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neurogene Inc. (NGNE)$0.625B-4.46
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
CorMedix Inc. (CRMD)United States$0.605B3.25
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Monopar Therapeutics (MNPR)United States$0.598B-34.82
Altimmune, Inc. (ALT)United States$0.593B-6.43
Climb Bio, Inc. (CLYM)United States$0.683B-13.03